"Ribose" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pentose active in biological systems usually in its D-form.
Below are MeSH descriptors whose meaning is more general than "Ribose".
Below are MeSH descriptors whose meaning is more specific than "Ribose".
This graph shows the total number of publications written about "Ribose" by people in Harvard Catalyst Profiles by year, and whether "Ribose" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 0 | 1 | 1 |
2004 | 0 | 1 | 1 |
2008 | 0 | 1 | 1 |
2009 | 1 | 0 | 1 |
2014 | 1 | 1 | 2 |
2016 | 1 | 1 | 2 |
2018 | 2 | 0 | 2 |
2020 | 1 | 0 | 1 |
2022 | 0 | 5 | 5 |
2023 | 3 | 1 | 4 |
Below are the most recent publications written about "Ribose" by people in Profiles.
-
Kidney function in patients with ovarian cancer treated with poly (ADP-ribose) polymerase (PARP) inhibitors. J Natl Cancer Inst. 2023 07 06; 115(7):831-837.
-
Salvage of ribose from uridine or RNA supports glycolysis in nutrient-limited conditions. Nat Metab. 2023 05; 5(5):765-776.
-
Effect of ribose incubation on physical, chemical, and mechanical properties of human cortical bone. J Mech Behav Biomed Mater. 2023 04; 140:105731.
-
The ribose methylation enzyme FTSJ1 has a conserved role in neuron morphology and learning performance. Life Sci Alliance. 2023 04; 6(4).
-
State of the Biomarker Science in Ovarian Cancer: A National Cancer Institute Clinical Trials Planning Meeting Report. JCO Precis Oncol. 2022 Oct; 6:e2200355.
-
RNA modifications in aging-associated cardiovascular diseases. Aging (Albany NY). 2022 09 29; 14(19):8110-8136.
-
Evaluation of Treatment With Talazoparib and Avelumab in Patients With Recurrent Mismatch Repair Proficient Endometrial Cancer. JAMA Oncol. 2022 09 01; 8(9):1317-1322.
-
Efficacy of subsequent chemotherapy for patients with BRCA1/2-mutated recurrent epithelial ovarian cancer progressing on olaparib versus placebo maintenance: post-hoc analyses of the SOLO2/ENGOT Ov-21 trial. Ann Oncol. 2022 10; 33(10):1021-1028.
-
Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update. J Clin Oncol. 2022 09 20; 40(27):3205-3221.
-
Ribose Alters the Photochemical Properties of the Nucleobase in Thionated Nucleosides. J Phys Chem Lett. 2021 Jul 22; 12(28):6707-6713.